Q2 2015 13F Holders as of 6/30/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
50.5M
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
13.2M
-
Shares change
-
+2.7M
-
Total reported value, excl. options
-
$232M
-
Value change
-
+$48.3M
-
Number of buys
-
65
-
Number of sells
-
-16
-
Price
-
$17.58
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q2 2015
87 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q2 2015.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.2M shares
of 50.5M outstanding shares and own 26.14% of the company stock.
Largest 10 shareholders include FMR LLC (1.86M shares), FEDERATED INVESTORS INC /PA/ (1.48M shares), Broadfin Capital, LLC (1.42M shares), BlackRock Fund Advisors (1.4M shares), VANGUARD GROUP INC (1.02M shares), JPMORGAN CHASE & CO (456K shares), DEERFIELD MANAGEMENT CO (449K shares), UBS GLOBAL ASSET MANAGEMENT AMERICAS INC (443K shares), STATE STREET CORP (365K shares), and RENAISSANCE TECHNOLOGIES LLC (317K shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.